Molecular mechanisms of inhibitor bindings to A-FABP deciphered by using molecular dynamics simulations and calculations of MM-GBSA

References

• A. Chmurzyńska, The multigene family of fatty acid-binding proteins (FABPs): Function, structure and polymorphism, J. Appl. Genet. 47 (2006), pp. 39–48. doi:10.1007/BF03194597.
   PubMed Web of Science ®Google Scholar
• J.F.C. Glatz and G.J. van der Vusse, Cellular fatty acid-binding proteins: Their function and physiological significance, Prog. Lipid Res. 35 (1996), pp. 243–282. doi:10.1016/s0163-7827(96)00006-9.
   PubMed Web of Science ®Google Scholar
• A. Vogel Hertzel and D.A. Bernlohr, The mammalian fatty acid-binding protein multigene family: Molecular and genetic insights into function, Trends Endocrin. Met. 11 (2000), pp. 175–180. doi:10.1016/S1043-2760(00)00257-5.
   PubMed Web of Science ®Google Scholar
• L. Banaszak, N. Winter, Z. Xu, D.A. Bernlohr, S. Cowan, and A.T. Jones, Lipid-binding proteins: A family of fatty acid and retinoid transport proteins, Adv. Protein Chem. 45 (1994), pp. 90–152. doi:10.1016/S0065-3233(08)60639-7.
   Google Scholar
• G.S. Hotamisligil, Inflammation and metabolic disorders, Nature 444 (2006), pp. 860–867. doi:10.1038/nature05485.
   PubMed Web of Science ®Google Scholar
• M. Furuhashi and G.S. Hotamisligil, Fatty acid-binding proteins: Role in metabolic diseases and potential as drug targets, Nat. Rev. Drug Discov. 7 (2008), pp. 489–503. doi:10.1038/nrd2589.
   PubMed Web of Science ®Google Scholar
• A. Reese-Wagoner, J. Thompson, and L. Banaszak, Structural properties of the adipocyte lipid binding protein, BBA-Mol. Cell Biol. L 1441 (1999), pp. 106–116. doi:10.1016/s1388-1981(99)00154-7.
   Google Scholar
• J. Ory, C.D. Kane, M.A. Simpson, L.J. Banaszak, and D.A. Bernlohr, Biochemical and crystallographic analyses of a portal mutant of the adipocyte lipid-binding protein, J. Biol. Chem. 272 (1997), pp. 9793–9801. doi:10.1074/jbc.272.15.9793.
   PubMed Web of Science ®Google Scholar
• J.J. Ory, A. Mazhary, H. Kuang, R.R. Davies, M.D. Distefano, and L.J. Banaszak, Structural characterization of two synthetic catalysts based on adipocyte lipid-binding protein, Protein Eng. Des. Sel. 11 (1998), pp. 253–261. doi:10.1093/protein/11.4.253.
   Google Scholar
• J.M. LaLonde, D.A. Bernlohr, and L.J. Banaszak, X-ray crystallographic structures of adipocyte lipid-binding protein complexed with palmitate and hexadecanesulfonic acid. Properties of cavity binding sites, Biochemistry 33 (1994), pp. 4885–4895. doi:10.1021/bi00182a017.
   PubMed Web of Science ®Google Scholar
• J.M. LaLonde, M.A. Levenson, J.J. Roe, D.A. Bernlohr, and L.J. Banaszak, Adipocyte lipid-binding protein complexed with arachidonic acid. Titration calorimetry and X-ray crystallographic studies, J. Biol. Chem. 269 (1994), pp. 25339–25347. doi:10.1016/S0021-9258(18)47253-5.
   PubMed Web of Science ®Google Scholar
• Z.H. Xu, M.K. Buelt, L.J. Banaszak, and D.A. Bernlohr, Expression, purification, and crystallization of the adipocyte lipid binding protein, J. Biol. Chem. 266 (1991), pp. 14367–14370. doi:10.1016/S0021-9258(18)98693-X.
   PubMed Web of Science ®Google Scholar
• Z. Xu, D.A. Bernlohr, and L.J. Banaszak, Crystal structure of recombinant murine adipocyte lipid-binding protein, Biochemistry 31 (1992), pp. 3484–3492. doi:10.1021/bi00128a024.
   PubMed Web of Science ®Google Scholar
• Z. Xu, D.A. Bernlohr, and L.J. Banaszak, The adipocyte lipid-binding protein at 1.6-A resolution. Crystal structures of the apoprotein and with bound saturated and unsaturated fatty acids, J. Biol. Chem. 268 (1993), pp. 7874–7884. doi:10.1016/S0021-9258(18)53039-8.
   PubMed Web of Science ®Google Scholar
• F. Lehmann, S. Haile, E. Axen, C. Medina, J. Uppenberg, S. Svensson, T. Lundbäck, L. Rondahl, and T. Barf, Discovery of inhibitors of human adipocyte fatty acid-binding protein, a potential type 2 diabetes target, Bioorg. Med. Chem. Lett. 14 (2004), pp. 4445–4448. doi:10.1016/j.bmcl.2004.06.057.
   PubMed Web of Science ®Google Scholar
• G.S. Hotamisligil, R.S. Johnson, R.J. Distel, R. Ellis, V.E. Papaioannou, and B.M. Spiegelman, Uncoupling of obesity from insulin resistance through a targeted mutation in ap2, the adipocyte fatty acid binding protein, Science 274 (1996), pp. 1377–1379. doi:10.1126/science.274.5291.1377.
   PubMed Web of Science ®Google Scholar
• N.R. Coe, M.A. Simpson, and D.A. Bernlohr, Targeted disruption of the adipocyte lipid-binding protein (aP2 protein) gene impairs fat cell lipolysis and increases cellular fatty acid levels, J. Lipid Res. 40 (1999), pp. 967–972. doi:10.1016/S0022-2275(20)32133-7.
   PubMed Web of Science ®Google Scholar
• K.T. Uysal, L. Scheja, S.M. Wiesbrock, S. Bonner-Weir, and G.K.S. Hotamisligil, improved glucose and lipid metabolism in genetically obese mice lacking aP2, Endocrinology 141 (2000), pp. 3388–3396. doi:10.1210/endo.141.9.7637.
   PubMed Web of Science ®Google Scholar
• M. Furuhashi, G. Tuncman, C.Z. Görgün, L. Makowski, G. Atsumi, E. Vaillancourt, K. Kono, V.R. Babaev, S. Fazio, M.F. Linton, R. Sulsky, J.A. Robl, R.A. Parker, and G.S. Hotamisligil, Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2, Nature 447 (2007), pp. 959–965. doi:10.1038/nature05844.
   PubMed Web of Science ®Google Scholar
• L. Makowski, J.B. Boord, K. Maeda, V.R. Babaev, K.T. Uysal, M.A. Morgan, R.A. Parker, J. Suttles, S. Fazio, G.S. Hotamisligil, and M.F. Linton, Lack of macrophage fatty-acid–binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis, Nat. Med. 7 (2001), pp. 699–705. doi:10.1038/89076.
   PubMed Web of Science ®Google Scholar
• L. Scheja, L. Makowski, K.T. Uysal, S.M. Wiesbrock, D.R. Shimshek, D.S. Meyers, M. Morgan, R.A. Parker, and G.S. Hotamisligil, Altered insulin secretion associated with reduced lipolytic efficiency in aP2-/- mice, Diabetes 48 (1999), pp. 1987–1994. doi:10.2337/diabetes.48.10.1987.
   PubMed Web of Science ®Google Scholar
• B. Vural, F. Atalar, C. Ciftci, A. Demirkan, B. Susleyici-Duman, D. Gunay, B. Akpinar, E. Sagbas, U. Ozbek, and A.S. Buyukdevrim, Presence of fatty-acid-binding protein 4 expression in human epicardial adipose tissue in metabolic syndrome, Cardiovasc. Pathol. 17 (2008), pp. 392–398. doi:10.1016/j.carpath.2008.02.006.
   PubMed Web of Science ®Google Scholar
• A. Cabré, I. Lázaro, J. Girona, J.M. Manzanares, F. Marimón, N. Plana, M. Heras, and L. Masana, Fatty acid binding protein 4 is increased in metabolic syndrome and with thiazolidinedione treatment in diabetic patients, Atherosclerosis 195 (2007), pp. e150–e158. doi:10.1016/j.atherosclerosis.2007.04.045.
   PubMedGoogle Scholar
• M. Furuhashi, Fatty acid-binding protein 4 in cardiovascular and metabolic diseases, J. Atheroscler. Thromb. 26 (2019), pp. 216–232. doi:10.5551/jat.48710.
   PubMed Web of Science ®Google Scholar
• L. Shu, R.L. Hoo, X. Wu, Y. Pan, I.P. Lee, L.Y. Cheong, S.R. Bornstein, X. Rong, J. Guo, and A. Xu, A-FABP mediates adaptive thermogenesis by promoting intracellular activation of thyroid hormones in brown adipocytes, Nat. Commun. 8 (2017), pp. 14147. doi:10.1038/ncomms14147.
   PubMed Web of Science ®Google Scholar
• C. Mathis, I. Lascombe, F. Monnien, H. Bittard, F. Kleinclauss, I. Bedgedjian, S. Fauconnet, and S. Valmary-Degano, Down-regulation of A-FABP predicts non-muscle invasive bladder cancer progression: Investigation with a long term clinical follow-up, BMC Cancer 18 (2018), pp. 1239. doi:10.1186/s12885-018-5137-4.
   PubMed Web of Science ®Google Scholar
• G. Llaverias, V. Noé, S. Peñuelas, M. Vázquez-Carrera, R.M. Sánchez, J.C. Laguna, C.J. Ciudad, and M. Alegret, Atorvastatin reduces CD68, FABP4, and HBP expression in oxLDL-treated human macrophages, Biochem. Bioph. Res. Co. 318 (2004), pp. 265–274. doi:10.1016/j.bbrc.2004.04.021.
   PubMed Web of Science ®Google Scholar
• R. Sulsky, D.R. Magnin, Y. Huang, L. Simpkins, P. Taunk, M. Patel, Y. Zhu, T.R. Stouch, D. Bassolino-Klimas, R. Parker, T. Harrity, R. Stoffel, D.S. Taylor, T.B. Lavoie, K. Kish, B.L. Jacobson, S. Sheriff, L.P. Adam, W.R. Ewing, and J.A. Robl, Potent and selective biphenyl azole inhibitors of adipocyte fatty acid binding protein (aFABP), Bioorg. Med. Chem. Lett. 17 (2007), pp. 3511–3515. doi:10.1016/j.bmcl.2006.12.044.
   PubMedGoogle Scholar
• J. Song, P. Ren, L. Zhang, X.L. Wang, L. Chen, and Y.H. Shen, Metformin reduces lipid accumulation in macrophages by inhibiting FOXO1-mediated transcription of fatty acid-binding protein 4, Biochem. Bioph. Res. Co. 393 (2010), pp. 89–94. doi:10.1016/j.bbrc.2010.01.086.
   PubMed Web of Science ®Google Scholar
• U. Tagami, K. Takahashi, S. Igarashi, C. Ejima, T. Yoshida, S. Takeshita, W. Miyanaga, M. Sugiki, M. Tokumasu, T. Hatanaka, T. Kashiwagi, K. Ishikawa, H. Miyano, and T. Mizukoshi, Interaction analysis of FABP4 inhibitors by x-ray crystallography and fragment molecular orbital analysis, ACS Med. Chem. Lett. 7 (2016), pp. 435–439. doi:10.1021/acsmedchemlett.6b00040.
   PubMed Web of Science ®Google Scholar
• J.M. Gonzalez and S.Z. Fisher, Structural analysis of ibuprofen binding to human adipocyte fatty-acid binding protein (FABP4), Acta Crystallogr. F 71 (2015), pp. 163–170. doi:10.1107/S2053230X14027897.
   Google Scholar
• D.-D. Gao, H.-X. Dou, H.-X. Su, -M.-M. Zhang, T. Wang, Q.-F. Liu, H.-Y. Cai, H.-P. Ding, Z. Yang, W.-L. Zhu, Y.-C. Xu, H.-Y. Wang, and Y.-X. Li, From hit to lead: Structure-based discovery of naphthalene-1-sulfonamide derivatives as potent and selective inhibitors of fatty acid binding protein 4, Eur. J. Med. Chem. 154 (2018), pp. 44–59. doi:10.1016/j.ejmech.2018.05.007.
   PubMed Web of Science ®Google Scholar
• A.V. Hertzel, K. Hellberg, J.M. Reynolds, A.C. Kruse, B.E. Juhlmann, A.J. Smith, M.A. Sanders, D.H. Ohlendorf, J. Suttles, and D.A. Bernlohr, Identification and characterization of a small molecule inhibitor of fatty acid binding proteins, J. Med. Chem. 52 (2009), pp. 6024–6031. doi:10.1021/jm900720m.
   PubMed Web of Science ®Google Scholar
• T. Barf, F. Lehmann, K. Hammer, S. Haile, E. Axen, C. Medina, J. Uppenberg, S. Svensson, L. Rondahl, and T. Lundbäck, N-Benzyl-indolo carboxylic acids: Design and synthesis of potent and selective adipocyte fatty-acid binding protein (A-FABP) inhibitors, Bioorg. Med. Chem. Lett. 19 (2009), pp. 1745–1748. doi:10.1016/j.bmcl.2009.01.084.
   PubMedGoogle Scholar
• E.L. Wu, Y. Mei, K. Han, and J.Z.H. Zhang, Quantum and molecular dynamics study for binding of macrocyclic inhibitors to human α-thrombin, Biophys. J. 92 (2007), pp. 4244–4253. doi:10.1529/biophysj.106.099150.
   PubMed Web of Science ®Google Scholar
• J. Chen, J. Wang, and W. Zhu, Binding modes of three inhibitors 8CA, F8A and I4A to A-FABP studied based on molecular dynamics simulation, Plos One 9 (2014), pp. e99862. doi:10.1371/journal.pone.0099862.
   PubMed Web of Science ®Google Scholar
• F. Yan, X. Liu, S. Zhang, J. Su, Q. Zhang, and J. Chen, Electrostatic interaction-mediated conformational changes of adipocyte fatty acid binding protein probed by molecular dynamics simulation, J. Biomol. Struct. Dyn. 37 (2019), pp. 3583–3595. doi:10.1080/07391102.2018.1520648.
   PubMed Web of Science ®Google Scholar
• M. De Vivo, M. Masetti, G. Bottegoni, and A. Cavalli, Role of molecular dynamics and related methods in drug discovery, J. Med. Chem. 59 (2016), pp. 4035–4061. doi:10.1021/acs.jmedchem.5b01684.
   PubMed Web of Science ®Google Scholar
• T.E. Cheatham, J. Srinivasan, D.A. Case, and P.A. Kollman, Molecular dynamics and continuum solvent studies of the stability of PolyG-PolyC and PolyA-PolyT DNA duplexes in solution, J. Biomol. Struct. Dyn. 16 (1998), pp. 265–280. doi:10.1080/07391102.1998.10508245.
   PubMed Web of Science ®Google Scholar
• D. Shi, Q. Bai, S. Zhou, X. Liu, H. Liu, and X. Yao, Molecular dynamics simulation, binding free energy calculation and unbinding pathway analysis on selectivity difference between FKBP51 and FKBP52: Insight into the molecular mechanism of isoform selectivity, Proteins 86 (2018), pp. 43–56. doi:10.1002/prot.25401.
   PubMed Web of Science ®Google Scholar
• J. Chen, X. Wang, L. Pang, J.Z.H. Zhang, and T. Zhu, Effect of mutations on binding of ligands to guanine riboswitch probed by free energy perturbation and molecular dynamics simulations, Nucleic Acids Res. 47 (2019), pp. 6618–6631. doi:10.1093/nar/gkz499.
   PubMed Web of Science ®Google Scholar
• J. Zhao, B. Yin, H. Sun, L. Pang, and J. Chen, Identifying hot spots of inhibitor-CDK2 bindings by computational alanine scanning, Chem. Phys. Lett. 747 (2020), pp. 137329. doi:10.1016/j.cplett.2020.137329.
   Web of Science ®Google Scholar
• J. Devillers, Computational Design of Chemicals for the Control of Mosquitoes and Their Diseases, CRC Press, Boca Raton, 2018.
   Google Scholar
• Y. Gao, T. Zhu, and J. Chen, Exploring drug-resistant mechanisms of I84V mutation in HIV-1 protease toward different inhibitors by thermodynamics integration and solvated interaction energy method, Chem. Phys. Lett. 706 (2018), pp. 400–408. doi:10.1016/j.cplett.2018.06.040.
   Web of Science ®Google Scholar
• H. Gohlke and D.A. Case, Converging free energy estimates: MM-PB(GB)SA studies on the protein–protein complex Ras–Raf, J. Comput. Chem. 25 (2004), pp. 238–250. doi:10.1002/jcc.10379.
   PubMed Web of Science ®Google Scholar
• I. Massova and P.A. Kollman, Combined molecular mechanical and continuum solvent approach (MM-PBSA/GBSA) to predict ligand binding, Perspect. Drug Discov. 18 (2000), pp. 113–135. doi:10.1023/A:1008763014207.
   Google Scholar
• H. Sun, Y. Li, M. Shen, S. Tian, L. Xu, P. Pan, Y. Guan, and T. Hou, Assessing the performance of MM/PBSA and MM/GBSA methods. 5. Improved docking performance using high solute dielectric constant MM/GBSA and MM/PBSA rescoring, Phys. Chem. Chem. Phys. 16 (2014), pp. 22035–22045. doi:10.1039/C4CP03179B.
   PubMed Web of Science ®Google Scholar
• H.K. Srivastava and G.N. Sastry, Molecular dynamics investigation on a series of HIV protease inhibitors: Assessing the performance of MM-PBSA and MM-GBSA approaches, J. Chem. Inf. Model. 52 (2012), pp. 3088–3098. doi:10.1021/ci300385h.
   PubMed Web of Science ®Google Scholar
• P. Lagarias, K. Barkan, E. Tzortzini, M. Stampelou, E. Vrontaki, G. Ladds, and A. Kolocouris, Insights to the binding of a selective adenosine A3 receptor antagonist using molecular dynamic simulations, MM-PBSA and MM-GBSA free energy calculations, and mutagenesis, J. Chem. Inf. Model. 59 (2019), pp. 5183–5197. doi:10.1021/acs.jcim.9b00751.
   PubMed Web of Science ®Google Scholar
• J. Chen, X. Wang, T. Zhu, Q. Zhang, and J.Z.H. Zhang, A comparative insight into amprenavir resistance of mutations V32I, G48V, I50V, I54V, and I84V in HIV-1 protease based on thermodynamic integration and MM-PBSA methods, J. Chem. Inf. Model. 55 (2015), pp. 1903–1913. doi:10.1021/acs.jcim.5b00173.
   PubMed Web of Science ®Google Scholar
• S. Tian, J. Zeng, X. Liu, J. Chen, J.Z.H. Zhang, and T. Zhu, Understanding the selectivity of inhibitors toward PI4KIIIα and PI4KIIIβ based molecular modeling, Phys. Chem. Chem. Phys. 21 (2019), pp. 22103–22112. doi:10.1039/C9CP03598B.
   PubMed Web of Science ®Google Scholar
• J. Chen, J. Wang, and W. Zhu, Mutation L1196M-induced conformational changes and the drug resistant mechanism of anaplastic lymphoma kinase studied by free energy perturbation and umbrella sampling, Phys. Chem. Chem. Phys. 19 (2017), pp. 30239–30248. doi:10.1039/C7CP05418A.
   PubMed Web of Science ®Google Scholar
• R.D. Keane and R.J. Adrian, Theory of cross-correlation analysis of PIV images, Appl. Sci. Res. 49 (1992), pp. 191–215. doi:10.1007/BF00384623.
   Google Scholar
• B. Podobnik and H.E. Stanley, Detrended cross-correlation analysis: A new method for analyzing two nonstationary time series, Phys. Rev. Lett. 100 (2008), pp. 084102. doi:10.1103/PhysRevLett.100.084102.
   PubMed Web of Science ®Google Scholar
• J. Chen, W. Wang, H. Sun, L. Pang, and B. Yin, Mutation-mediated influences on binding of anaplastic lymphoma kinase to crizotinib decoded by multiple replica Gaussian accelerated molecular dynamics, J. Comput. Aid. Mol. Des. 34 (2020), pp. 1289–1305. doi:10.1007/s10822-020-00355-5.
   PubMed Web of Science ®Google Scholar
• J. Zhao, H. Sun, W. Wang, L. Zhang, and J. Chen, Theoretical insights into mutation-mediated conformational changes of the GNP-bound H-RAS, Chem. Phys. Lett. 759 (2020), pp. 138042. doi:10.1016/j.cplett.2020.138042.
   Web of Science ®Google Scholar
• S. Wold, K. Esbensen, and P. Geladi, Principal component analysis, Chemom. Intell. Lab. 2 (1987), pp. 37–52. doi:10.1016/0169-7439(87)80084-9.
   Web of Science ®Google Scholar
• H. Abdi and L.J. Williams, Principal component analysis, WIREs Comput. Stat. 2 (2010), pp. 433–459. doi:10.1002/wics.101.
   Google Scholar
• M.E. Tipping and C.M. Bishop, Probabilistic principal component analysis, J. R. Stat. Soc. B 61 (1999), pp. 611–622. doi:10.1111/1467-9868.00196.
   Google Scholar
• J. Chen, W. Wang, L. Pang, and W. Zhu, Unveiling conformational dynamics changes of H-Ras induced by mutations based on accelerated molecular dynamics, Phys. Chem. Chem. Phys. 22 (2020), pp. 21238–21250. doi:10.1039/D0CP03766D.
   PubMed Web of Science ®Google Scholar
• F. Yan, X. Liu, S. Zhang, J. Su, Q. Zhang, and J. Chen, Molecular dynamics exploration of selectivity of dual inhibitors 5M7, 65X, and 65Z toward fatty acid binding proteins 4 and 5, Int. J. Mol. Sci. 19 (2018), pp. 2496. doi:10.3390/ijms19092496.
   PubMed Web of Science ®Google Scholar
• J. Chen, X. Liu, S. Zhang, J. Chen, H. Sun, L. Zhang, and Q. Zhang, Molecular mechanism with regard to the binding selectivity of inhibitors toward FABP5 and FABP7 explored by multiple short molecular dynamics simulations and free energy analyses, Phys. Chem. Chem. Phys. 22 (2020), pp. 2262–2275. doi:10.1039/C9CP05704H.
   PubMed Web of Science ®Google Scholar
• G. Hu, A. Ma, and J. Wang, Ligand selectivity mechanism and conformational changes in guanine riboswitch by molecular dynamics simulations and free energy calculations, J. Chem. Inf. Model. 57 (2017), pp. 918–928. doi:10.1021/acs.jcim.7b00139.
   PubMed Web of Science ®Google Scholar
• J. Chen, J. Wang, B. Yin, L. Pang, W. Wang, and W. Zhu, Molecular mechanism of binding selectivity of inhibitors toward BACE1 and BACE2 revealed by multiple short molecular dynamics simulations and free-energy predictions, ACS Chem. Neurosci. 10 (2019), pp. 4303–4318. doi:10.1021/acschemneuro.9b00348.
   PubMed Web of Science ®Google Scholar
• S.L. Wu, L.F. Wang, H.B. Sun, W. Wang, and Y.X. Yu, Probing molecular mechanism of inhibitor bindings to bromodomain-containing protein 4 based on molecular dynamics simulations and principal component analysis, SAR QSAR Environ. Res. 31 (2020), pp. 547–570. doi:10.1080/1062936X.2020.1777584.
   PubMed Web of Science ®Google Scholar
• L.F. Wang, Y. Wang, Z.Y. Yang, J. Zhao, H.B. Sun, and S.L. Wu, Revealing binding selectivity of inhibitors toward bromodomain-containing proteins 2 and 4 using multiple short molecular dynamics simulations and free energy analyses, SAR QSAR Environ. Res. 31 (2020), pp. 373–398. doi:10.1080/1062936X.2020.1748107.
   PubMed Web of Science ®Google Scholar
• D.A. Case, T.E. Cheatham III, T. Darden, H. Gohlke, R. Luo, K.M. Merz Jr, A. Onufriev, C. Simmerling, B. Wang, and R.J. Woods, The Amber biomolecular simulation programs, J. Comput. Chem. 26 (2005), pp. 1668–1688. doi:10.1002/jcc.20290.
   PubMed Web of Science ®Google Scholar
• T.-S. Lee, D.S. Cerutti, D. Mermelstein, C. Lin, S. LeGrand, T.J. Giese, A. Roitberg, D.A. Case, R.C. Walker, and D.M. York, GPU-accelerated molecular dynamics and free energy methods in Amber18: Performance enhancements and new features, J. Chem. Inf. Model. 58 (2018), pp. 2043–2050. doi:10.1021/acs.jcim.8b00462.
   PubMed Web of Science ®Google Scholar
• A. Jakalian, B.L. Bush, D.B. Jack, and C.I. Bayly, Fast, efficient generation of high-quality atomic charges. AM1-BCC model: I. Method, J. Comput. Chem. 21 (2000), pp. 132–146. doi:10.1002/(SICI)1096-987X(20000130)21:2<132::AID-JCC5>3.0.CO;2-P.
   Web of Science ®Google Scholar
• A. Jakalian, D.B. Jack, and C.I. Bayly, Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation, J. Comput. Chem. 23 (2002), pp. 1623–1641. doi:10.1002/jcc.10128.
   PubMed Web of Science ®Google Scholar
• X. He, V.H. Man, W. Yang, T.-S. Lee, and J. Wang, A fast and high-quality charge model for the next generation general AMBER force field, J. Chem. Phys. 153 (2020), pp. 114502. doi:10.1063/5.0019056.
   PubMed Web of Science ®Google Scholar
• J.A. Maier, C. Martinez, K. Kasavajhala, L. Wickstrom, K.E. Hauser, and C. Simmerling, ff14SB: Improving the accuracy of protein side chain and backbone parameters from ff99SB, J. Chem. Theory Comput. 11 (2015), pp. 3696–3713. doi:10.1021/acs.jctc.5b00255.
   PubMed Web of Science ®Google Scholar
• J. Wang, R.M. Wolf, J.W. Caldwell, P.A. Kollman, and D.A. Case, Development and testing of a general amber force field, J. Comput. Chem. 25 (2004), pp. 1157–1174. doi:10.1002/jcc.20035.
   PubMed Web of Science ®Google Scholar
• K.G. Sprenger, V.W. Jaeger, and J. Pfaendtner, The general AMBER force field (GAFF) can accurately predict thermodynamic and transport properties of many ionic liquids, J. Phys. Chem. B 119 (2015), pp. 5882–5895. doi:10.1021/acs.jpcb.5b00689.
   PubMed Web of Science ®Google Scholar
• J.P.M. Jämbeck and A.P. Lyubartsev, Update to the general amber force field for small solutes with an emphasis on free energies of hydration, J. Phys. Chem. B 118 (2014), pp. 3793–3804. doi:10.1021/jp4111234.
   PubMed Web of Science ®Google Scholar
• W.L. Jorgensen, J. Chandrasekhar, J.D. Madura, R.W. Impey, and M.L. Klein, Comparison of simple potential functions for simulating liquid water, J. Chem. Phys. 79 (1983), pp. 926–935. doi:10.1063/1.445869.
   Web of Science ®Google Scholar
• D.J. Price and C.L. Brooks III, A modified TIP3P water potential for simulation with Ewald summation, J. Chem. Phys. 121 (2004), pp. 10096–10103. doi:10.1063/1.1808117.
   PubMed Web of Science ®Google Scholar
• P. Mark and L. Nilsson, Structure and dynamics of the TIP3P, SPC, and SPC/E water models at 298 K, J. Phys. Chem. A 105 (2001), pp. 9954–9960. doi:10.1021/jp003020w.
   Web of Science ®Google Scholar
• S. Miyamoto and P.A. Kollman, Settle: An analytical version of the SHAKE and RATTLE algorithm for rigid water models, J. Comput. Chem. 13 (1992), pp. 952–962. doi:10.1002/jcc.540130805.
   Web of Science ®Google Scholar
• U. Essmann, L. Perera, M.L. Berkowitz, T. Darden, H. Lee, and L.G. Pedersen, A smooth particle mesh Ewald method, J. Chem. Phys. 103 (1995), pp. 8577–8593. doi:10.1063/1.470117.
   Web of Science ®Google Scholar
• T. Darden, D. York, and L. Pedersen, Particle mesh Ewald: An Nlog(N) method for Ewald sums in large systems, J. Chem. Phys. 98 (1993), pp. 10089–10092. doi:10.1063/1.464397.
   Web of Science ®Google Scholar
• R. Salomon-Ferrer, A.W. Götz, D. Poole, S. Le Grand, and R.C. Walker, Routine microsecond molecular dynamics simulations with AMBER on GPUs. 2. Explicit solvent particle mesh Ewald, J. Chem. Theory Comput. 9 (2013), pp. 3878–3888. doi:10.1021/ct400314y.
   PubMed Web of Science ®Google Scholar
• D.R. Roe and T.E. Cheatham, PTRAJ and CPPTRAJ: Software for processing and analysis of molecular dynamics trajectory data, J. Chem. Theory Comput. 9 (2013), pp. 3084–3095. doi:10.1021/ct400341p.
   PubMed Web of Science ®Google Scholar
• H. Sun, Y. Li, S. Tian, L. Xu, and T. Hou, Assessing the performance of MM/PBSA and MM/GBSA methods. 4. Accuracies of MM/PBSA and MM/GBSA methodologies evaluated by various simulation protocols using PDBbind data set, Phys. Chem. Chem. Phys. 16 (2014), pp. 16719–16729. doi:10.1039/C4CP01388C.
   PubMed Web of Science ®Google Scholar
• E. Wang, G. Weng, H. Sun, H. Du, F. Zhu, F. Chen, Z. Wang, and T. Hou, Assessing the performance of the MM/PBSA and MM/GBSA methods. 10. Impacts of enhanced sampling and variable dielectric model on protein–protein interactions, Phys. Chem. Chem. Phys. 21 (2019), pp. 18958–18969. doi:10.1039/C9CP04096J.
   PubMed Web of Science ®Google Scholar
• L.L. Duan, T. Zhu, Y.C. Li, Q.G. Zhang, and J.Z.H. Zhang, Effect of polarization on HIV-1protease and fluoro-substituted inhibitors binding energies by large scale molecular dynamics simulations, Sci. Rep. 7 (2017), pp. 42223. doi:10.1038/srep42223.
   PubMed Web of Science ®Google Scholar
• J. Chen, B. Yin, W. Wang, and H. Sun, effects of disulfide bonds on binding of inhibitors to β-amyloid cleaving enzyme 1 decoded by multiple replica accelerated molecular dynamics smulations, ACS Chem. Neurosci. 11 (2020), pp. 1811–1826. doi:10.1021/acschemneuro.0c00234.
   PubMed Web of Science ®Google Scholar